About: Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 20 October 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в жовтні 2013 (uk) مقالة علمية نشرت في 20 أكتوبر 2013 (ar) scientific article published on 20 October 2013 (en)
publication date	wds:Q37280515-E53B18F6-5AE0-45AB-92C0-C26B3A5EB24C
publication date	2013-10-20 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37280515-EA4C0B01-C797-4B4F-8FE2-689EAE094EF2
language of work or name	English
cites work	wds:Q37280515-05264FD5-79A6-440B-AF66-F74AB9907B0F wds:Q37280515-08EBE497-8ECB-4CD4-9AD3-A81ADEE93202 wds:Q37280515-13F9E934-C384-4729-B854-38EBC9C42EB8 wds:Q37280515-164F5E80-6DC7-4897-93E6-AD4424BF1DCB wds:Q37280515-2309A0D2-7CF5-4E80-8CDE-249999E062B3 wds:Q37280515-23E1EF65-625B-418B-9E19-8DB1CBB60AD1 wds:Q37280515-28B1F273-2CE8-4C10-80EF-D688F708C307 wds:Q37280515-2D2D6BDA-F81B-4C62-9717-51DABEEDA0EB wds:Q37280515-2E051BF2-A230-4277-9684-5CF6D3A92AA2 wds:Q37280515-336566F8-BCF4-4550-8C05-7314D968A257 wds:Q37280515-381DF1AE-187E-409F-BDE7-E57B67505AC6 wds:Q37280515-4D978648-2736-4EE2-AA34-8F07C9F9298C wds:Q37280515-5AA928FB-113D-4C30-9FDF-920968F59285 wds:Q37280515-657B6600-A487-4E4C-9829-A246EB533ED9 wds:Q37280515-7AB4BEA8-FAFF-445C-92B1-E3DE710FCDDD wds:Q37280515-7E3BC493-4234-4315-88B9-39F3657A65FE wds:Q37280515-98C1F566-106C-4C8F-9416-46844D6EDE85 wds:Q37280515-9C32A434-2FC1-4682-9DEE-7E1984FFB8F5 wds:Q37280515-9E8B5A4F-5F95-4DE7-BDA2-BCE9A979D1AB wds:Q37280515-A4455130-BED7-4DBC-9E6A-F501544E02D3 wds:Q37280515-A66F96FC-BA52-4B5F-879E-80C896E03873 wds:Q37280515-B1EA4349-BC0C-45A6-B460-542764B88EDB wds:Q37280515-C7F1963F-1FA5-431D-8BF5-CBE28049BAC9 wds:Q37280515-C955058C-FCC6-441E-8DC6-866087ACC4A2 wds:Q37280515-D2B0B4CE-E4CF-4DDD-92CC-FBBE849C82BA wds:Q37280515-E0CD45CF-E3D2-48B9-A5D4-4C07A75F52A1 wds:Q37280515-E1F48B1E-F901-41B9-8008-E4CC42F4825F
cites work	Approaches for the development of solid and semi-solid lipid-based formulations. Chylomicrons promote intestinal absorption of lipopolysaccharides Drug delivery and nanoparticles:applications and hazards Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery Lipid-based formulations for intestinal lymphatic delivery The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system. Skeletal and nonskeletal effects of raloxifene Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery Clinical studies with oral lipid based formulations of poorly soluble compounds Effects of raloxifene hydrochloride on endometrial cancer cells in vitro Lipid-based vehicle for oral drug delivery. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation SERM Drugs for the Prevention of Osteoporosis Effect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administration
author name string	wds:Q37280515-2D162723-637E-45B7-9D2B-809A8193DE1C wds:Q37280515-77FABEB5-432B-4266-BC30-95661010C28B wds:Q37280515-9AC8203A-E16A-4CFA-9ABF-C29ADEE79CC1 wds:Q37280515-B4DCFED4-5ECB-4D2F-9C47-1F8689E1CDFE
author name string	Sanjay Singh Sanjay Kumar Singh Anand Kumar Kushwaha Priyanka Karunanidhi
rdfs:label	Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (en) Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (nl) Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (ast)
skos:prefLabel	Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (en) Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (nl) Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (ast)
name	Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (en) Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (nl) Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. (ast)
author	wds:Q37280515-C06FCC2B-7982-482F-9F42-DD85230F88FA
author	Parameswara Rao Vuddanda
title	wds:Q37280515-1428516F-AE90-4864-B880-8A522999277D
title	Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability (en)
page(s)	wds:Q37280515-7A7CA1D3-335E-493A-8BE5-29262FC0A474
page(s)	584549
instance of	wds:Q37280515-4C723960-7557-4D11-8A57-043634FF7172
instance of	scholarly article

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software